PC94ICD-11 MMS 2026-01
Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
Index terms
- Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
- Intentional overdose of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs
- intentional self-poisoning by and exposure to nonopioid analgesics, antipyretics and antirheumatics
Show allHide
- Intentional self-harm by exposure to or harmful effects of aspirin
- Intentional overdose of aspirin
- Intentional self-poisoning by exposure to or harmful effects of aspirin
- Intentional self-harm by exposure to or harmful effects of other salicylates
- Intentional overdose of other salicylates
- Intentional self-poisoning by exposure to or harmful effects of other salicylates
- Intentional self-harm by exposure to or harmful effects of paracetamol
- Intentional overdose of paracetamol
- Intentional self-poisoning by exposure to or harmful effects of paracetamol
- Intentional self-harm by exposure to or harmful effects of 4-Aminophenol derivatives
- Intentional overdose of 4-Aminophenol derivatives
- Intentional self-poisoning by exposure to or harmful effects of 4-Aminophenol derivatives
- Intentional self-harm by exposure to or harmful effects of ibuprofen
- Intentional overdose of ibuprofen
- Intentional self-poisoning by exposure to or harmful effects of ibuprofen
- Intentional self-harm by exposure to or harmful effects of pyrazolone derivatives
- Intentional overdose of pyrazolone derivatives
- Intentional self-poisoning by exposure to or harmful effects of pyrazolone derivatives
- Intentional self-harm by exposure to or harmful effects of other propionic acid derivatives
- Intentional overdose of other propionic acid derivatives
- Intentional self-poisoning by exposure to or harmful effects of other propionic acid derivatives
- Intentional self-harm by exposure to or harmful effects of indomethacin
- Intentional overdose of indomethacin
- Intentional self-poisoning by exposure to or harmful effects of indomethacin
- Intentional self-harm by exposure to or harmful effects of other nonsteroidal anti-inflammatory drugs
- Intentional overdose of NSAID - [nonsteroidal anti-inflammatory drugs]
- Intentional overdose of other nonsteroidal anti-inflammatory drugs
- Intentional self-poisoning by exposure to or harmful effects of other nonsteroidal anti-inflammatory drugs
- Intentional self-harm by exposure to or harmful effects of antirheumatics, not elsewhere classified
- Intentional overdose of antirheumatics, not elsewhere classified
- Intentional self-poisoning by exposure to or harmful effects of antirheumatics, not elsewhere classified
Exclusions from above levels
- http://id.who.int/icd/entity/1583926619 – Substances associated with injury or harm with therapeutic intent
Sibling codes
PC90– Intentional self-harm by exposure to or harmful effects of opioids or related analgesicsPC91– Intentional self-harm by exposure to or harmful effects of sedative hypnotic drugs or other CNS depressantsPC92– Intentional self-harm by exposure to or harmful effects of psychostimulantsPC93– Intentional self-harm by exposure to or harmful effects of cannabinoids or hallucinogensPC95– Intentional self-harm by exposure to or harmful effects of antidepressantsPC96– Intentional self-harm by exposure to or harmful effects of antipsychoticsPC97– Intentional self-harm by exposure to or harmful effects of antiepileptics or antiparkinsonism drugsPC98– Intentional self-harm by exposure to other or unspecified drug, medicament or biological substancePC99– Intentional self-harm by exposure to or harmful effects of multiple drugs, medicaments or biological substances
Foundation entity
Intentional self-harm by exposure to or harmful effects of analgesics, antipyretics or nonsteroidal anti-inflammatory drugs – http://id.who.int/icd/entity/1505618598
Allowed postcoordination axes
Part of: 23: External causes of morbidity or mortality